[ALNY] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
15-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -19.69%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 492,853 219,750 74,908 89,912 47,159 41,097 50,561 46.10%
PBT -855,600 -885,253 -760,674 -490,874 -410,108 -290,073 -400,604 13.46%
Tax 2,681 863 823 -25,603 -23,438 -24,909 -40,209 -
NP -858,281 -886,116 -761,497 -490,874 -410,108 -290,073 -360,395 15.54%
Tax Rate - - - - - - - -
Total Cost 1,351,134 1,105,866 836,405 580,786 457,267 331,170 410,956 21.91%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -174.15 -403.24 -1,016.58 -545.95 -869.63 -705.83 -712.79 -20.91%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 7.43%
EPS Diluted -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 7.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.